Delgado, Jorge-Shmuel <br/><br/>
Sorafenib triggers antiproliferative and pro-apoptotic signals in human esophageal adenocarcinoma cells.  [electronic resource] 

 -  Digestive diseases and sciences  Dec 2008 
 - 3055-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0163-2116 
<br/><br/><label>Standard No.: </label>10.1007/s10620-008-0294-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Benzenesulfonates--pharmacology<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cyclin D1--metabolism<br/>Cyclin E--metabolism<br/>Esophageal Neoplasms--drug therapy<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Humans<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Proto-Oncogene Proteins c-myc--metabolism<br/>Pyridines--pharmacology<br/>STAT3 Transcription Factor--metabolism<br/>Sorafenib<br/>p38 Mitogen-Activated Protein Kinases--metabolism